{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:45:34Z","timestamp":1781354734712,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant pleural mesothelioma (MPM) is an aggressive tumor with an unfavorable prognosis. The standard therapeutic approaches are limited to surgery, chemotherapy, and radiotherapy. Because the consequent clinical outcome is often unsatisfactory, a different approach in MPM treatment is required. S100A11, a Ca<jats:sup>2+<\/jats:sup>-binding small protein with two EF-hands, is frequently upregulated in various human cancers. Interestingly, it has been found that intracellular and extracellular S100A11 have different functions in cell viability. In this study, we focused on the impact of extracellular S100A11 in MPM and explored the therapeutic potential of an S100A11-targeting strategy. We examined the secretion level of S100A11 in various kinds of cell lines by enzyme-linked immunosorbent assay. Among them, six out of seven MPM cell lines actively secreted S100A11, whereas normal mesothelial cell lines did not secrete it. To investigate the role of secreted S100A11 in MPM, we inhibited its function by neutralizing S100A11 with an anti-S100A11 antibody. Interestingly, the antibody significantly inhibited the proliferation of S100A11-secreting MPM cells in vitro and in vivo. Microarray analysis revealed that several pathways including genes involved in cell proliferation were negatively enriched in the antibody-treated cell lines. In addition, we examined the secretion level of S100A11 in various types of pleural effusions. We found that the secretion of S100A11 was significantly higher in MPM pleural effusions, compared to others, suggesting the possibility for the use of S100A11 as a biomarker. In conclusion, our results indicate that extracellular S100A11 plays important roles in MPM and may be a therapeutic target in S100A11-secreting MPM.<\/jats:p>","DOI":"10.1038\/s41389-017-0017-3","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T09:33:40Z","timestamp":1516613620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma"],"prefix":"10.1038","volume":"7","author":[{"given":"Hiroki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakiyo","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-5460","authenticated-orcid":false,"given":"Hiromasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Aoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-4220","authenticated-orcid":false,"given":"Kazuhiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidejiro","family":"Torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Tsukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1097\/JTO.0b013e3181f1cf2b","volume":"5","author":"MT Milano","year":"2010","unstructured":"Milano, M. T. & Zhang, H. Malignant pleural mesothelioma: a population-based study of survival. J. Thorac. Oncol. 5, 1841\u20131848 (2010).","journal-title":"J. Thorac. Oncol."},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson, B. W. & Lake, R. A. Advances in malignant mesothelioma. N. Engl. J. Med. 353, 1591\u20131603 (2005).","journal-title":"N. Engl. J. Med."},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick, A. R., Weber, D. J. & Zimmer, D. B. S100 proteins in cancer. Nat. Rev. Cancer 15, 96\u2013109 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 33, 637\u2013668 (2001).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1091\/mbc.E07-07-0682","volume":"19","author":"M Sakaguchi","year":"2008","unstructured":"Sakaguchi, M. et al. S100A11, an dual mediator for growth regulation of human keratinocytes. Mol. Biol. Cell. 19, 78\u201385 (2008).","journal-title":"Mol. Biol. Cell."},{"key":"17_CR6","doi-asserted-by":"crossref","first-page":"18668","DOI":"10.1016\/S0021-9258(18)55115-2","volume":"266","author":"H Todoroki","year":"1991","unstructured":"Todoroki, H., Kobayashi, R., Watanabe, M., Minami, H. & Hidaka, H. Purification, characterization, and partial sequence analysis of a newly identified EF-hand type 13-kDa Ca(2+)-binding protein from smooth muscle and non-muscle tissues. J. Biol. Chem. 266, 18668\u201318673 (1991).","journal-title":"J. Biol. Chem."},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1083\/jcb.200304017","volume":"163","author":"M Sakaguchi","year":"2003","unstructured":"Sakaguchi, M. et al. S100C\/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J. Cell. Biol. 163, 825\u2013835 (2003).","journal-title":"J. Cell. Biol."},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"35679","DOI":"10.1074\/jbc.M707538200","volume":"282","author":"M Sakaguchi","year":"2007","unstructured":"Sakaguchi, M. et al. Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells. J. Biol. Chem. 282, 35679\u201335686 (2007).","journal-title":"J. Biol. Chem."},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00726-010-0747-4","volume":"41","author":"M Sakaguchi","year":"2011","unstructured":"Sakaguchi, M. & Huh, N. H. S100A11, a dual growth regulator of epidermal keratinocytes. Amino Acids 41, 797\u2013807 (2011).","journal-title":"Amino Acids"},{"key":"17_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4795","volume":"5","author":"JK Jaiswal","year":"2014","unstructured":"Jaiswal, J. K. et al. S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells. Nat. Commun. 5, 3795 (2014).","journal-title":"Nat. Commun."},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-09-4439","volume":"70","author":"J Shankar","year":"2010","unstructured":"Shankar, J. et al. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res. 70, 3780\u20133790 (2010).","journal-title":"Cancer Res."},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12307-016-0185-2","volume":"9","author":"S Saho","year":"2016","unstructured":"Saho, S. et al. Active secretion of dimerized S100A11 induced by the peroxisome in mesothelioma cells. Cancer Microenviron. 9, 93\u2013105 (2016).","journal-title":"Cancer Microenviron."},{"issue":"M110","key":"17_CR13","first-page":"000901","volume":"10","author":"C Fan","year":"2011","unstructured":"Fan, C. et al. S100A11 mediates hypoxia-induced mitogenic factor (HIMF)-induced smooth muscle cell migration, vesicular exocytosis, and nuclear activation. Mol. Cell. Proteom. 10(M110), 000901 (2011).","journal-title":"Mol. Cell. Proteom."},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"E1591","DOI":"10.1210\/jc.2013-1652","volume":"98","author":"MC Anania","year":"2013","unstructured":"Anania, M. C. et al. S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, E1591\u2013E1600 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11010-011-1026-8","volume":"359","author":"J Hao","year":"2012","unstructured":"Hao, J. et al. Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells. Mol. Cell. Biochem. 359, 323\u2013332 (2012).","journal-title":"Mol. Cell. Biochem."},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1158\/1078-0432.CCR-06-0222","volume":"12","author":"K Ohuchida","year":"2006","unstructured":"Ohuchida, K. et al. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis. Clin. Cancer Res. 12, 5417\u20135422 (2006).","journal-title":"Clin. Cancer Res."},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1158\/0008-5472.CAN-03-3514","volume":"64","author":"N Oue","year":"2004","unstructured":"Oue, N. et al. Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 64, 2397\u20132405 (2004).","journal-title":"Cancer Res."},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/1078-0432.606.11.2","volume":"11","author":"AA Memon","year":"2005","unstructured":"Memon, A. A. et al. Down-regulation of S100C is associated with bladder cancer progression and poor survival. Clin. Cancer Res. 11, 606\u2013611 (2005).","journal-title":"Clin. Cancer Res."},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori, O. et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752\u201325761 (1995).","journal-title":"J. Biol. Chem."},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2174\/156652407783220750","volume":"7","author":"H Rauvala","year":"2007","unstructured":"Rauvala, H. & Rouhiainen, A. RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr. Mol. Med. 7, 725\u2013734 (2007).","journal-title":"Curr. Mol. Med."},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan, S. D. et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer\u2019s disease. Nature 382, 685\u2013691 (1996).","journal-title":"Nature"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"8296","DOI":"10.4049\/jimmunol.175.12.8296","volume":"175","author":"DL Cecil","year":"2005","unstructured":"Cecil, D. L. et al. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 175, 8296\u20138302 (2005).","journal-title":"J. Immunol."},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1086\/604730","volume":"200","author":"MA van Zoelen","year":"2009","unstructured":"van Zoelen, M. A. et al. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice. J. Infect. Dis. 200, 765\u2013773 (2009).","journal-title":"J. Infect. Dis."},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/BF02505229","volume":"288","author":"B Algermissen","year":"1996","unstructured":"Algermissen, B., Sitzmann, J., LeMotte, P. & Czarnetzki, B. Differential expression of CRABP II, psoriasin and cytokeratin 1 mRNA in human skin diseases. Arch. Dermatol. Res. 288, 426\u2013430 (1996).","journal-title":"Arch. Dermatol. Res."},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jacc.2006.02.077","volume":"48","author":"K Hirono","year":"2006","unstructured":"Hirono, K. et al. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease. J. Am. Coll. Cardiol. 48, 1257\u20131264 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann, M. A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 97, 889\u2013901 (1999).","journal-title":"Cell"},{"key":"17_CR27","first-page":"126","volume":"91","author":"C Sorg","year":"1992","unstructured":"Sorg, C. The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation. Behring Inst. Mitt. 91, 126\u2013137 (1992).","journal-title":"Behring Inst. Mitt."},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","volume":"59","author":"HI Pass","year":"1995","unstructured":"Pass, H. I. et al. Characteristics of nine newly derived mesothelioma cell lines. Ann. Thorac. Surg. 59, 835\u2013844 (1995).","journal-title":"Ann. Thorac. Surg."},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jcb.240630505","volume":"24","author":"RM Phelps","year":"1996","unstructured":"Phelps, R. M. et al. NCI-Navy Medical Oncology Branch cell line data base. J. Cell. Biochem. Suppl. 24, 32\u201391 (1996).","journal-title":"J. Cell. Biochem. Suppl."},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3892\/ol.2015.3955","volume":"11","author":"K Suzawa","year":"2016","unstructured":"Suzawa, K. et al. Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma. Oncol. Lett. 11, 705\u2013712 (2016).","journal-title":"Oncol. Lett."},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cllc.2012.02.003","volume":"13","author":"K Shien","year":"2012","unstructured":"Shien, K. et al. Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers. Clin. Lung Cancer 13, 488\u2013493 (2012).","journal-title":"Clin. Lung Cancer"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.lungcan.2012.02.006","volume":"77","author":"K Shien","year":"2012","unstructured":"Shien, K. et al. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Lung Cancer 77, 162\u2013167 (2012).","journal-title":"Lung Cancer"},{"key":"17_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep40847","volume":"7","author":"H Sato","year":"2017","unstructured":"Sato, H. et al. Targeting the miR-200c\/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features. Sci. Rep. 7, 40847 (2017).","journal-title":"Sci. Rep."},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.lungcan.2011.10.002","volume":"76","author":"N Tanaka","year":"2012","unstructured":"Tanaka, N. et al. Frequent methylation and oncogenic role of microRNA-34b\/c in small-cell lung cancer. Lung Cancer 76, 32\u201338 (2012).","journal-title":"Lung Cancer"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-017-0017-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-017-0017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-017-0017-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:08:01Z","timestamp":1671534481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-017-0017-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1038\/s41389-017-0017-3","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"assertion":[{"value":"27 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"11"}}